Angsuman Chakraborty13 Jul 2005 11:28 pm
He’s not a politician, a tycoon, or a pop star. But these days, Hwang Woo Suk may enjoy more popularity and respect in South Korea than the hottest celebrity. He is a pioneer of embryonic stem cell research — and a national hero. The government even issued a postage stamp in his honor in February that juxtaposes an image of growing stem cells with silhouettes of a man rising from a wheelchair, walking, and embracing another person.
This is the respect he richly deserves for bringing South Korea to the forefront of Stem Cell Research.
Hwang’s accomplishment has emerged from a country that has not been a leader in basic science. He was first to reach the goal of “personalizing” stem cell lines, in part because rival U.S. scientists have been hampered by restrictions on federal funding for embryonic stem cell research. While some Koreans share President George W. Bush’s ethical concerns in this area, surveys show that the vast majority support Hwang’s work. Most seem to agree with him that the potential medical benefits outweigh other considerations. “Hopes of giving new life and joy to those suffering from incurable diseases make me renew my determination,” Hwang says — adding that he will remain sensitive to other people’s worries and “bear them in mind to make sure I won’t veer off course.”
Hwang was born during the Korean War and grew up in a poor mountain town in the central Korean province of South Chungcheong. His father died when he was 5, and his mother borrowed money to buy a cow, which became his family’s most valuable possession. As a schoolboy, Hwang helped care for the animal. “I learned to communicate with the cow eye to eye and decided to become a veterinarian,” he says.
In the near term, Hwang’s goal is to show that laboratory-engineered stem cells can help heal damaged spinal cords in rats, dogs, and possibly monkeys. If these trials go well, in two to three years he’ll seek permission to conduct human trials in Korea and the U.S. Whatever direction the stem cell debate may take overseas, to Hwang it’s all about saving lives.
I wish him success with all my heart. Such men are the messiah’s of the new century.
Link [www.businessweek.com/magazine/content/05_29/b3943026.htm]
Filed under Stem Cell | Comment Below
Related?
Meet The Active Supporters of Stem Cell ResearchFebruary 24th, 2006 Who are the real supporters of Stem Cell Research?
Meet Claire LeVine from Walnut Creek in California. Claire loves to watch her 7 year-old grandson, Bobby Stearns, play his heart out in Little League.
Groundbreaking stem cell therapy may cure Crohn's disease and acute colitisJune 25th, 2009 The technique involves replacing old stem cells from bone marrow which are responsible for the disease, with the fresh and new stem cells. Leading researcher Professor Chris Hawkey, a
gastroenterologist at Nottingham University, claimed that the study results able to prove that autologous stem cell transplantation holds promise in eliminating the symptoms of Crohn's disease
It is also claimed to be the worlds first stem cell transplantation trial of its kind that able to raise some hope to clear the symptoms of the Crohn's disease for much longer times than ever.
Stem Cell Research Center at University Of Massachusetts March 7th, 2007 The University of Massachusetts could position itself as a contender in the stem cell research arena by developing a new system-wide institute to advance life sciences through human and animal research, according to a report to the university's board of trustees. UMass trustees plan to discuss the proposal when they meet March 14th in Worcester.
Internationally Acclaimed Cardiothoracic Surgeon and Pioneer of Stem Cell Research Dr Amit Patel Joins LifeCellOctober 19th, 2006 LifeCell, pioneers in stem cell banking and research in India, today announced that Dr Amit N Patel has joined its scientific advisory board. Dr Patel is an internationally acclaimed cardiothoracic surgeon and pioneer of stem cell research and therapies for cardiac disorders.
Top US Government Stem Cell Scientist Quits Over Bush's Stem Cell PolicyApril 17th, 2006 The leader of the stem-cell unit at the National Institute on Aging, part of the National Institutes of Health, announced today he will leave the NIH to join the private sector at a biotech company called Invitrogen in Carlsbad, California. Dr. Mahendra Rao, the leader of the stem cell unit at the National Institute on Aging says the president Bush's 2001 policy decision lies at the root of his decision to leave the government for the private sector.
UMass Trustees Yesterday Approved the Plan for Stem Cell InstituteMarch 15th, 2007 University of Massachusetts trustees yesterday approved a plan to ask the state for $66.4 million over six years to launch a stem-cell institute. The proposed institute would back research at all five UMass campuses, but particularly at the Amherst campus and at the UMass Medical School in Worcester.
NIH discovery confirms a new direction for stem cell storage facilitiesMarch 28th, 2009 An important discovery reported on Wednesday, March 25 by researchers at the National Institutes of Health (NIH; www.nih.gov). The new discovery by NIH researchers has implications for Leukemia treatment and artificially culturing blood cells, that validates a new direction for stem cell "storage" facilities that meet rigid state and federal regulatory requirements.
Stem cell drug for 10,000 plus patients from a single donorJune 20th, 2009 Indian biotech company Stempeutic Research Pvt Ltd, a group company of Manipal Group, able to achieve the land mark of producing stem cell drug for over 10,000 patients from a single healthy donor. The holy intention to discover a super first method that can expand MSCs (Mesenchymal Stem Cells) growth to make the stem cell therapy affordable to the common people was the main goal that mobilize the inspiration to invent this innovative method.
Leave a Comment